Bilobalide inhibits 6-OHDA-induced activation of NF-κB and loss of dopaminergic neurons in rat substantia nigra
暂无分享,去创建一个
[1] Y. Christen,et al. EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] T. Chase,et al. NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53 , 2007, Brain Research.
[3] S. Dolan,et al. Oral administration of Ginkgo biloba extract, EGb‐761 inhibits thermal hyperalgesia in rodent models of inflammatory and post‐surgical pain , 2007, British journal of pharmacology.
[4] V. Kumar,et al. Bilobalide prevents ischemia-induced edema formation in vitro and in vivo , 2007, Neuroscience.
[5] M. Vacca,et al. Ginkgo biloba Leaf Extract Reverses Amyloid β-Peptide-Induced Isoprostane Production in Rat Brain in vitro , 2006, Planta medica.
[6] Yongmoon Han. Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritic inflammation. , 2005, International immunopharmacology.
[7] J. Andersen,et al. Cell in focusDopaminergic neurons , 2005 .
[8] Rajnish Kumar Chaturvedi,et al. Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences , 2005, Journal of neurochemistry.
[9] E. Tercan,et al. Antioxidant effect of EGb 761 on hydrogen peroxide‐induced lipoperoxidation of G‐6‐PD deficient erythrocytes , 2004, Phytotherapy research : PTR.
[10] Y. Oh,et al. Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant. , 2004, Biochemical and biophysical research communications.
[11] L. Siklós,et al. The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease , 2004 .
[12] Markus Schwaninger,et al. The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[13] J. Dichgans,et al. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation , 2003 .
[14] B. Ahlemeyer,et al. Neuroprotective effects of Ginkgo biloba extract , 2003, Cellular and Molecular Life Sciences CMLS.
[15] G. Fiskum,et al. Neuroprotective Effects of Bilobalide, a Component of Ginkgo biloba Extract (EGb 761®) in Global Brain Ischemia and in Excitotoxicity-induced Neuronal Death , 2003 .
[16] B. Ahlemeyer,et al. Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s Disease , 2003, Pharmacopsychiatry.
[17] G. Fiskum,et al. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. , 2002, Cellular and molecular biology.
[18] M. Grundman,et al. Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.
[19] J. Remacle,et al. Mitochondrial respiratory chain as a new target for anti-ischemic molecules. , 2002, European journal of pharmacology.
[20] G. Fiskum,et al. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia , 2001, Brain Research.
[21] A. Barzilai,et al. Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease? , 2001, Cellular and Molecular Neurobiology.
[22] A. Barzilai,et al. Activation of nuclear transcription factor kappa B (NF‐κB) is essential for dopamine‐induced apoptosis in PC12 cells , 2001, Journal of neurochemistry.
[23] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[24] L. Zhou,et al. Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. , 2000, The Journal of pharmacology and experimental therapeutics.
[25] C. Michiels,et al. Protection by bilobalide of the ischaemia‐induced alterations of the mitochondrial respiratory activity , 2000, Fundamental & clinical pharmacology.
[26] Y. Christen,et al. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extrac3t (EGb 761) , 2000, Mechanisms of Ageing and Development.
[27] M. Hilgert,et al. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[28] S. Mandel,et al. The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators , 1999, Annals of the New York Academy of Sciences.
[29] Z. Qin,et al. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. , 1999, Molecular pharmacology.
[30] Xing-zu Zhu,et al. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. , 1999, Life sciences.
[31] T. Chase,et al. Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.
[32] B. Ahlemeyer,et al. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. , 1999, European journal of pharmacology.
[33] Y Agid,et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Chatterjee,et al. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba , 1997, Brain Research.
[35] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[36] Fred H. Gage,et al. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior , 1991, Brain Research.
[37] Cao Fei,et al. Experimental study on inhibition of neuronal toxical effect of Levodopa by Ginkgo Biloba Extract on Parkinson disease in rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].
[38] G. Kreutzberg,et al. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema , 2004, Acta Neuropathologica.
[39] Yuan Luo,et al. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.
[40] J. Westman,et al. Antioxidant compounds EGB-761 and BN-52021 attenuate brain edema formation and hemeoxygenase expression following hyperthermic brain injury in the rat. , 2003, Acta neurochirurgica. Supplement.
[41] S. Mandel,et al. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.
[42] R. Xiu,et al. The therapeutic effect of Ginkgo biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. , 2000, Clinical hemorheology and microcirculation.
[43] A. Wettstein. Cholinesterase inhibitors and Ginkgo extracts — are they comparable in the treatment of dementia? , 2000 .
[44] T. Chase,et al. Nuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum , 1998 .
[45] I. Ziv,et al. Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process? , 1997, Journal of neural transmission. Supplementum.